These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 23030458
1. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance. Sarisozen C, Vural I, Levchenko T, Hincal AA, Torchilin VP. Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458 [Abstract] [Full Text] [Related]
2. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells. Sarisozen C, Vural I, Levchenko T, Hincal AA, Torchilin VP. Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922 [Abstract] [Full Text] [Related]
3. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. Wang F, Zhang D, Zhang Q, Chen Y, Zheng D, Hao L, Duan C, Jia L, Liu G, Liu Y. Biomaterials; 2011 Dec; 32(35):9444-56. PubMed ID: 21903258 [Abstract] [Full Text] [Related]
4. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. Wong HL, Bendayan R, Rauth AM, Wu XY. J Control Release; 2006 Dec 01; 116(3):275-84. PubMed ID: 17097178 [Abstract] [Full Text] [Related]
5. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. Wang J, Qu H, Jin L, Zeng W, Qin L, Zhang F, Wei X, Lu W, Zhang C, Liang W. J Pharm Sci; 2011 Jun 01; 100(6):2267-77. PubMed ID: 21246559 [Abstract] [Full Text] [Related]
6. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Chavanpatil MD, Patil Y, Panyam J. Int J Pharm; 2006 Aug 31; 320(1-2):150-6. PubMed ID: 16713148 [Abstract] [Full Text] [Related]
7. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance. Jin X, Mo R, Ding Y, Zheng W, Zhang C. Mol Pharm; 2014 Jan 06; 11(1):145-57. PubMed ID: 24261922 [Abstract] [Full Text] [Related]
8. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance. Ji X, Gao Y, Chen L, Zhang Z, Deng Y, Li Y. Int J Pharm; 2012 Jan 17; 422(1-2):390-7. PubMed ID: 22001531 [Abstract] [Full Text] [Related]
9. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution. Liu Y, Sun J, Lian H, Cao W, Wang Y, He Z. J Pharm Sci; 2014 May 17; 103(5):1538-47. PubMed ID: 24619562 [Abstract] [Full Text] [Related]
10. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O, van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, Hennink WE. J Control Release; 2005 Mar 21; 103(2):341-53. PubMed ID: 15763618 [Abstract] [Full Text] [Related]
11. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. Zhu X, Sui M, Fan W. Anticancer Res; 2005 Mar 21; 25(3B):1953-62. PubMed ID: 16158930 [Abstract] [Full Text] [Related]
12. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J, Sun J, Chen Q, Gao Y, Li L, Li H, Leng D, Wang Y, Sun Y, Jing Y, Wang S, He Z. Biomaterials; 2012 Oct 21; 33(28):6877-88. PubMed ID: 22770799 [Abstract] [Full Text] [Related]
13. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP. Int J Pharm; 2006 Jun 06; 315(1-2):148-57. PubMed ID: 16616818 [Abstract] [Full Text] [Related]
14. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles. Tonbul H, Şahin A, Öztürk SC, Ultav G, Tavukçuoğlu E, Akbaş S, Aktaş Y, Esendağlı G, Çapan Y. J Drug Target; 2024 Nov 06; 32(9):1101-1110. PubMed ID: 38946465 [Abstract] [Full Text] [Related]
15. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Zhang J, Zhao X, Chen Q, Yin X, Xin X, Li K, Qiao M, Hu H, Chen D, Zhao X. Acta Biomater; 2017 Mar 01; 50():381-395. PubMed ID: 27956367 [Abstract] [Full Text] [Related]
16. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. Patil Y, Sadhukha T, Ma L, Panyam J. J Control Release; 2009 May 21; 136(1):21-9. PubMed ID: 19331851 [Abstract] [Full Text] [Related]
17. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH. Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169 [Abstract] [Full Text] [Related]
18. Cargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicin. Singh MS, Lamprecht A. Int J Pharm; 2015 Jan 30; 478(2):745-52. PubMed ID: 25437111 [Abstract] [Full Text] [Related]
19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K. Cancer Chemother Pharmacol; 2002 May 30; 49(5):391-7. PubMed ID: 11976833 [Abstract] [Full Text] [Related]
20. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel. Ouahab A, Shao C, Shen Y, Tu J. Drug Dev Ind Pharm; 2014 Jul 30; 40(7):860-8. PubMed ID: 23600653 [Abstract] [Full Text] [Related] Page: [Next] [New Search]